1. Home
  2. TME vs MEDP Comparison

TME vs MEDP Comparison

Compare TME & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tencent Music Entertainment Group each representing two

TME

Tencent Music Entertainment Group each representing two

N/A

Current Price

$8.28

Market Cap

16.2B

ML Signal

N/A

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

N/A

Current Price

$591.35

Market Cap

16.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TME
MEDP
Founded
N/A
1992
Country
China
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2B
16.6B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
TME
MEDP
Price
$8.28
$591.35
Analyst Decision
Buy
Hold
Analyst Count
8
12
Target Price
$19.44
$473.17
AVG Volume (30 Days)
10.7M
177.6K
Earning Date
05-12-2026
04-22-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
20.98
EPS
N/A
8.53
Revenue
N/A
N/A
Revenue This Year
$10.73
$13.19
Revenue Next Year
$10.19
$7.75
P/E Ratio
$15.69
$68.84
Revenue Growth
N/A
N/A
52 Week Low
$7.94
$373.00
52 Week High
$26.70
$677.90

Technical Indicators

Market Signals
Indicator
TME
MEDP
Relative Strength Index (RSI) 37.52 48.88
Support Level $7.94 $566.12
Resistance Level $9.92 $628.29
Average True Range (ATR) 0.24 16.97
MACD -0.06 -5.08
Stochastic Oscillator 14.36 27.54

Price Performance

Historical Comparison
TME
MEDP

About TME Tencent Music Entertainment Group each representing two

Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: